Table 3.
GLS | LAVI | |||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate% | Univariate | Multivariate% | |||||
r | P | Beta (%95CI)& | P | r | P | Beta (%95CI)& | P | |
Age | -0.116$ | 0.290 | 0.184 | 0.097 | 0.139$ | 0.209 | 0.192 | 0.076 |
eGFR | 0.124$ | 0.213 | -0.002 | 0.984 | -0.139$ | 0.211 | 0.333 (0.074–0.593) | 0.013 |
β-2µ | -0.247# | 0.021 | -0.037 (-0.062, -0.013) | 0.004 | 0.313# | 0.004 | 2.793 (1.355–4.231) | <0.001 |
Hgb | 0.092# | 0.405 | 0.027 | 0.813 | -0.325# | 0.003 | -1.854 (-3.028, -0.680) | 0.012 |
iPTH | -0.115# | 0.308 | -0.064 | 0.567 | -0.004# | 0.975 | -0.105 | 0.356 |
CaXPh | -0.075# | 0.498 | 0.024 | 0833 | -0.009# | 0.939 | -0.154 | 0.200 |
Diuretic | -1.078%,* | 0.227 | -0.065 | 0.561 | 7.763%,* | 0.030 | 8.340(1.819-14.861) | 0.036 |
PWV | -0.190$ | 0.092 | -0.073 | 0.553 | 0.107$ | 0.351 | 0.126 | 0.231 |
Sys BP | -0.227$ | 0.036 | -0.146 | 0.204 | 0.052$ | 0.641 | -0.132 | 0.241 |
DiaBP | -0.133$ | 0.225 | 0.106 | 0.481 | 0.003$ | 0.979 | -0.126 | 0.243 |
C sys BP | -0.267$ | 0.015 | 0.139 | 0.495 | 0.135$ | 0.236 | -0.122 | 0.289 |
C dia BP | -0.142$ | 0.205 | 0.090 | 0.559 | -0.019$ | 0.871 | -0.120 | 0.129 |
MAP | -0.220$ | 0.050 | 0.264 | 0.447 | 0.077$ | 0.498 | -0.115 | 0.111 |
PP | -0.231$ | 0.031 | -0.146 | 0.339 | 0.112$ | 0.322 | -0.080 | 0.487 |
Aug I | 0.045$ | 0.693 | 0.094 | 0.419 | -0.561$ | 0.598 | -0.092 | 0.387 |
Aug P | 0.038$ | 0.737 | 0.132 | 0.271 | 0.070$ | 0.545 | -0.089 | 0.862 |
Pearson correlation;
Spearman correlation;
Linear regression;
CI denoted if it was only statistically significant;
Beta; Aug I - augmentation index;
Aug P - augmentation pressure; BP - blood pressure; C - central; Dia - diastolic; eGFR - estimated glomerular filtration rate; Hgb - hemoglobin; iPTH - intact parathormone; MAP - mean arterial pressure; PP - pulse pressure; Sys - systolic